Clinical guideline: management of gastroparesis
- PMID: 23147521
- PMCID: PMC3722580
- DOI: 10.1038/ajg.2012.373
Clinical guideline: management of gastroparesis
Abstract
This guideline presents recommendations for the evaluation and management of patients with gastroparesis. Gastroparesis is identified in clinical practice through the recognition of the clinical symptoms and documentation of delayed gastric emptying. Symptoms from gastroparesis include nausea, vomiting, early satiety, postprandial fullness, bloating, and upper abdominal pain. Management of gastroparesis should include assessment and correction of nutritional state, relief of symptoms, improvement of gastric emptying and, in diabetics, glycemic control. Patient nutritional state should be managed by oral dietary modifications. If oral intake is not adequate, then enteral nutrition via jejunostomy tube needs to be considered. Parenteral nutrition is rarely required when hydration and nutritional state cannot be maintained. Medical treatment entails use of prokinetic and antiemetic therapies. Current approved treatment options, including metoclopramide and gastric electrical stimulation (GES, approved on a humanitarian device exemption), do not adequately address clinical need. Antiemetics have not been specifically tested in gastroparesis, but they may relieve nausea and vomiting. Other medications aimed at symptom relief include unapproved medications or off-label indications, and include domperidone, erythromycin (primarily over a short term), and centrally acting antidepressants used as symptom modulators. GES may relieve symptoms, including weekly vomiting frequency, and the need for nutritional supplementation, based on open-label studies. Second-line approaches include venting gastrostomy or feeding jejunostomy; intrapyloric botulinum toxin injection was not effective in randomized controlled trials. Most of these treatments are based on open-label treatment trials and small numbers. Partial gastrectomy and pyloroplasty should be used rarely, only in carefully selected patients. Attention should be given to the development of new effective therapies for symptomatic control.
Figures
Comment in
-
Update on clinical guidelines for the management of gastroparesis.Am J Gastroenterol. 2013 Sep;108(9):1538-9. doi: 10.1038/ajg.2013.212. Am J Gastroenterol. 2013. PMID: 24005360 No abstract available.
-
Response to Arnold and Beaves.Am J Gastroenterol. 2013 Sep;108(9):1539-40. doi: 10.1038/ajg.2013.215. Am J Gastroenterol. 2013. PMID: 24005361 No abstract available.
Similar articles
-
Gastric electrical stimulation: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1. Ont Health Technol Assess Ser. 2006. PMID: 23074486 Free PMC article.
-
Gastroparesis in children.Curr Opin Pediatr. 2015 Jun;27(3):377-82. doi: 10.1097/MOP.0000000000000216. Curr Opin Pediatr. 2015. PMID: 25944312 Review.
-
[Gastroparesis and its treatment options].Orv Hetil. 2008 Mar 2;149(9):393-8. doi: 10.1556/OH.2008.28293. Orv Hetil. 2008. PMID: 18292033 Review. Hungarian.
-
Gastroparesis and its management.Rev Med Chir Soc Med Nat Iasi. 2001 Jul-Sep;105(3):451-6. Rev Med Chir Soc Med Nat Iasi. 2001. PMID: 12092172 Review.
-
Idiopathic gastroparesis.Gastroenterol Clin North Am. 2015 Mar;44(1):59-68. doi: 10.1016/j.gtc.2014.11.015. Epub 2014 Dec 24. Gastroenterol Clin North Am. 2015. PMID: 25667023 Free PMC article. Review.
Cited by
-
Prevalence and Severity of Diabetic Gastroparesis Symptoms in Relation to Diabetics in Saudi Arabia.Cureus. 2024 Oct 20;16(10):e71920. doi: 10.7759/cureus.71920. eCollection 2024 Oct. Cureus. 2024. PMID: 39564066 Free PMC article.
-
A bibliometric analysis of diabetic gastroparesis from 1979 to 2024.Front Med (Lausanne). 2024 Oct 10;11:1445276. doi: 10.3389/fmed.2024.1445276. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39450111 Free PMC article.
-
A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis.Surg Endosc. 2024 Oct 24. doi: 10.1007/s00464-024-11184-0. Online ahead of print. Surg Endosc. 2024. PMID: 39448403
-
Inuit population have shorter gastric emptying, higher duodenal motility and altered pan-enteric micromilieu: a comparative study between Greenlandic and Danish populations with and without type 2 diabetes.Int J Circumpolar Health. 2024 Dec;83(1):2392406. doi: 10.1080/22423982.2024.2392406. Epub 2024 Aug 16. Int J Circumpolar Health. 2024. PMID: 39151145 Free PMC article.
-
The presentation of two rare idiopathic diseases in one patient: spontaneous idiopathic pneumoperitoneum and idiopathic gastroparesis: a case report.Ann Med Surg (Lond). 2024 Jun 24;86(8):4799-4802. doi: 10.1097/MS9.0000000000002170. eCollection 2024 Aug. Ann Med Surg (Lond). 2024. PMID: 39118695 Free PMC article.
References
-
- Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239–1255. - PubMed
-
- Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783–788. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
